Anesthetic-induced corneal lesions in developmentally sensitive rats

Area of Science:

• Toxicology
• Developmental Biology
• Ophthalmology

Background:

• Developmental critical periods for induced abnormalities extend beyond early organogenesis.
• Anesthetic agents are widely used and may have unforeseen developmental impacts.

Purpose of the Study:

• To investigate the potential for anesthetic agents to induce corneal abnormalities during postnatal development.
• To explore the role of alpha 2 adrenergic receptors in mediating these effects.

Main Methods:

• Rat pups received a single injection of ketamine hydrochloride and xylazine during the third postnatal week.
• A separate group received ketamine hydrochloride, xylazine, and yohimbine.
• Corneal epithelial calcium deposition and lesions were assessed.

Main Results:

• 84% of rat pups exposed to ketamine hydrochloride and xylazine developed corneal epithelial calcium deposition.
• Concurrent administration of yohimbine reduced corneal lesions to 6%.

Conclusions:

• Ketamine hydrochloride and xylazine can induce corneal abnormalities in a specific postnatal developmental window.
• Yohimbine, an alpha 2 adrenergic receptor antagonist, mitigates these drug-induced corneal effects.
• Further research is needed to elucidate the exact mechanisms, potentially involving neurally directed corneal development or desiccation.